TrialAntimicrobial agents and chemotherapy2019

Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting

Zoltan Magyarics et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.